^
    over1year
    EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer (clinicaltrials.gov)
    P1, N=30, Recruiting, Second Affiliated Hospital of Guangzhou Medical University | Trial completion date: May 2025 --> May 2035 | Trial primary completion date: May 2025 --> May 2030
    Trial completion date • Trial primary completion date • Metastases
    |
    EGFR (Epidermal growth factor receptor) • CD276 (CD276 Molecule)
    |
    Undisclosed EGFR/B7H3 CAR-T
    over3years
    EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer (clinicaltrials.gov)
    P1, N=30, Recruiting, Second Affiliated Hospital of Guangzhou Medical University
    New P1 trial
    |
    EGFR (Epidermal growth factor receptor) • CD276 (CD276 Molecule)
    |
    EGFR expression • CD276 expression
    |
    Undisclosed EGFR/B7H3 CAR-T